144 related articles for article (PubMed ID: 28535250)
1. Evidence for the Deregulation of Protein Turnover Pathways in Atm-Deficient Mouse Cerebellum: An Organotypic Study.
Kim CD; Reed RE; Juncker MA; Fang Z; Desai SD
J Neuropathol Exp Neurol; 2017 Jul; 76(7):578-584. PubMed ID: 28535250
[TBL] [Abstract][Full Text] [Related]
2. ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells.
Desai SD; Reed RE; Babu S; Lorio EA
J Biol Chem; 2013 Jan; 288(4):2388-402. PubMed ID: 23212917
[TBL] [Abstract][Full Text] [Related]
3. A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway.
Wood LM; Sankar S; Reed RE; Haas AL; Liu LF; McKinnon P; Desai SD
PLoS One; 2011 Jan; 6(1):e16422. PubMed ID: 21298066
[TBL] [Abstract][Full Text] [Related]
4. Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype.
Tal E; Alfo M; Zha S; Barzilai A; De Zeeuw CI; Ziv Y; Shiloh Y
DNA Repair (Amst); 2018 Dec; 72():10-17. PubMed ID: 30348496
[TBL] [Abstract][Full Text] [Related]
5. ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cells.
Juncker M; Kim C; Reed R; Haas A; Schwartzenburg J; Desai S
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166102. PubMed ID: 33617986
[TBL] [Abstract][Full Text] [Related]
6. Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency.
Jiang D; Zhang Y; Hart RP; Chen J; Herrup K; Li J
Brain; 2015 Dec; 138(Pt 12):3520-36. PubMed ID: 26510954
[TBL] [Abstract][Full Text] [Related]
7. Disproportionate Expression of ATM in Cerebellar Cortex During Human Neurodevelopment.
Deacon S; Dalleywater W; Peat C; Paine SML; Dineen RA
Cerebellum; 2024 Apr; 23(2):502-511. PubMed ID: 37120494
[TBL] [Abstract][Full Text] [Related]
8. Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease.
Saunders RA; Michniacki TF; Hames C; Moale HA; Wilke C; Kuo ME; Nguyen J; Hartlerode AJ; Moore BB; Sekiguchi JM
Sci Rep; 2021 Feb; 11(1):4268. PubMed ID: 33608602
[TBL] [Abstract][Full Text] [Related]
9. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
Lavin MF
DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the ATM-Mediated DNA Damage Response in the Cerebellum Using Organotypic Cultures.
Tal E; Shiloh Y
Methods Mol Biol; 2017; 1599():419-430. PubMed ID: 28477136
[TBL] [Abstract][Full Text] [Related]
11. Ataxia telangiectasia syndrome: moonlighting ATM.
Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.
Sharma NK; Lebedeva M; Thomas T; Kovalenko OA; Stumpf JD; Shadel GS; Santos JH
DNA Repair (Amst); 2014 Jan; 13():22-31. PubMed ID: 24342190
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences.
Song X; Ma F; Herrup K
J Neurosci; 2019 Aug; 39(32):6378-6394. PubMed ID: 31189575
[TBL] [Abstract][Full Text] [Related]
14. Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice.
Hui CW; Song X; Ma F; Shen X; Herrup K
J Neuroinflammation; 2018 Nov; 15(1):308. PubMed ID: 30400801
[TBL] [Abstract][Full Text] [Related]
15. Ataxia telangiectasia: a review.
Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of Ataxia-telangiectasia mutated gene in miniature pigs by somatic cell nuclear transfer.
Kim YJ; Ahn KS; Kim M; Kim MJ; Park SM; Ryu J; Ahn JS; Heo SY; Kang JH; Choi YJ; Choi SJ; Shim H
Biochem Biophys Res Commun; 2014 Oct; 452(4):901-5. PubMed ID: 25193705
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination capabilities in response to neocarzinostatin and H(2)O(2) stress in cell lines from patients with ataxia-telangiectasia.
Taylor A; Shang F; Nowell T; Galanty Y; Shiloh Y
Oncogene; 2002 Jun; 21(28):4363-73. PubMed ID: 12080467
[TBL] [Abstract][Full Text] [Related]
18. Ataxia telangiectasia: new neurons and ATM.
McKinnon PJ
Trends Mol Med; 2001 Jun; 7(6):233-4. PubMed ID: 11378498
[TBL] [Abstract][Full Text] [Related]
19. Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telangiectasia.
Soares HD; Morgan JI; McKinnon PJ
Neuroscience; 1998 Oct; 86(4):1045-54. PubMed ID: 9697112
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of ATM-competent cells.
Pietzner J; Baer PC; Duecker RP; Merscher MB; Satzger-Prodinger C; Bechmann I; Wietelmann A; Del Turco D; Doering C; Kuci S; Bader P; Schirmer S; Zielen S; Schubert R
Hum Mol Genet; 2013 Feb; 22(3):493-507. PubMed ID: 23100326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
